June 23 at 1:30 pm PDT / 4:30 pm EDT  

This session will begin with a conversation with Ranking Member, Energy and Commerce Committee, US House of Representatives, Cathy McMorris Rodgers followed by a panel discussion.

During the pandemic, in the face of cascading health and social crises, health and science leaders illuminated the path forward. Massive scientific investments led to groundbreaking advancements in vaccination and therapy. Unprecedented collaboration in the public and private sectors enabled remarkable progress across industries. Telehealth and digital tools proved the potential of technologies to respond to health challenges. But the pandemic revealed a darker side as well. Wide gaps and disparities in healthcare delivery, quality, and access led to tragic outcomes as underserved communities and under-resourced countries struggled in the pandemic's grip. Will we heed the lessons of COVID-19? To build on the successes and combat the failures, solutions will require innovation and commitment from across the health ecosystem. Our panel of experts will discuss the possibilities.
 

Part 1

Guest

Cathy McMorris Rodgers 
US Representative, Washington; Ranking Member, Energy and Commerce Committee, US House of Representatives
 

Moderator

Mary Ellen McIntire 
Staff Reporter, Roll Call
 

Part 2

Moderator

Sam Baker
Health Editor, Axios
 

Speakers

Amy Abernethy 
former Principal Deputy Commissioner, US Food and Drug Administration

Kelvin Baggett 
Executive Vice President and Chief Impact Officer, McKesson

Tanisha Carino 
Executive Vice President and Chief Corporate Affairs Officer, Alexion Pharmaceuticals

Gary Michelson 
Founder and Co-Chair, Michelson Medical Research Foundation

Andrew Plump 
President, Research and Development, Takeda Pharmaceuticals
 

Materials

Optimizing a "New" Normal for Faster Innovation